Ventricular assist devices (VADs) are an important type of mechanical circulatory support (MCS) that assist the heart in pumping blood throughout the body. Depending on the clinical application, VADs can be divided into temporary and durable devices. Durable VADs are implantable ventricular assist devices (the main representative of implantable artificial hearts), which can meet patients' long-term circulatory support needs. They can serve as a bridging therapy to heart transplantation or cardiac rehabilitation, or as a long-term treatment option to replace cardiac function. From 2019 to 2024, affected by the COVID-19 pandemic, the global market size of implantable ventricular assist devices remained at around US$1 billion. From 2020 to 2024, the market size of implantable ventricular assist devices in my country increased from RMB 1 million to RMB 260 million, with a CAGR of 339.8%. It is projected that the market size of implantable ventricular assist devices in my country will reach RMB 5.7 billion by 2033, with a CAGR of 40.8% from 2024 to 2033.
Ventricular assist devices (VADs) are an important type of mechanical circulatory support (MCS) that assist the heart in pumping blood throughout the body. Depending on the clinical application, VADs can be divided into temporary and durable devices. Durable VADs are implantable ventricular assist devices (the main representative of implantable artificial hearts), which can meet patients' long-term circulatory support needs. They can serve as a bridging therapy to heart transplantation or cardiac rehabilitation, or as a long-term treatment option to replace cardiac function. From 2019 to 2024, affected by the COVID-19 pandemic, the global market size of implantable ventricular assist devices remained at around US$1 billion. From 2020 to 2024, the market size of implantable ventricular assist devices in my country increased from RMB 1 million to RMB 260 million, with a CAGR of 339.8%. It is projected that the market size of implantable ventricular assist devices in my country will reach RMB 5.7 billion by 2033, with a CAGR of 40.8% from 2024 to 2033.
